Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification
Concomitant
Immunostaining
DOI:
10.1007/s00125-021-05545-w
Publication Date:
2021-09-07T19:02:21Z
AUTHORS (5)
ABSTRACT
Abstract Aims/hypothesis Type 2 diabetes has been demonstrated to predispose aortic valve calcification. We investigated whether type concomitant stenosis (AS) enhances valvular inflammation and coagulation activation via upregulated expression of NF-κB, with subsequent increased bone morphogenetic protein (BMP-2). Methods In this case–control study, 50 individuals severe isolated AS were compared a control group 100 without diabetes. The median (IQR) duration since diagnosis was 11 (7–18) years, 36 (72%) had HbA 1c ≥48 mmol/mol (≥6.5%). Stenotic valves obtained during replacement surgery served for in loco BMP-2, prothrombin (FII) active factor X (FXa) immunostaining. vitro cultures interstitial cells (VICs), from used mechanistic experiments PCR investigations. Results Diabetic non-diabetic displayed enhanced FII FXa (all p ≤ 0.001). Moreover, the NF-κB BMP-2 positively correlated amounts FXa. Only diabetic participants, strongly associated serum levels , moderately fructosamine. Of importance, area (AVA) maximal transvalvular pressure gradient. conducted using VIC revealed that glucose (11 mmol/l) both ( < treated combination reactive oxygen species (ROS) inhibitor N -acetyl- l -cysteine), significantly suppressed. A comparable effect observed VICs cultured (BAY 11–7082), suggesting high doses activate oxidative stress leading proinflammatory actions VICs. Analysis mRNA confirmed these findings; caused 6.9-fold increase RELA (NF-κB p65 subunit), ROS reducing raised by 1.8- 3.2-fold, respectively. Conclusions/interpretation within stenotic leaflets. Increased is not only fructosamine but also AVA gradient, indicating strict long-term glycaemic needed patients This study suggests maintaining variables normal range may slow rate progression. Graphical abstract
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (24)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....